Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 millionInvivyd in vitro data showed continued ...

Ensitrelvir is a SARS-CoV-2 main protease inhibitor created through joint research between Hokkaido University and Shionogi. SARS-CoV-2 has an enzyme called the main protease, which is essential for ...

Infectious disease experts have sought to reassure people that the hantavirus cruise ship outbreak poses very low risks to ...

The “cicada” SARS-CoV-2 variant, which earned its nickname after staying relatively dormant following its discovery in 2024, has accounted for a small proportion of COVID-19 cases since the CDC began ...

A new Covid variant, BA.3.2, is spreading across the US, raising concerns among health experts. This video breaks down what we know about this emerging strain, its potential impact, and how it differs ...

Dr. Judith O’Donnell joined us to explain the emerging “Cicada” COVID-19 variant and share important facts about hantavirus, ...

Alberta’s COVID-19 death toll continues to decline. While the trend is positive news, experts warn most of these deaths are ...

BA.3.2 or Cicada is currently spreading in the United States. A heavily mutated variant is able to evade immunity from vacc.

The emergence of the BA.3.2 strain comes amid broader uneasiness about COVID vaccination rates among seniors, who are especially susceptible to the virus.

A hantavirus outbreak tied to a cruise ship has placed 18 Americans under medical monitoring as the WHO confirms 11 cases and ...

A Covid-19 variant dubbed “cicada” is showing signs of spreading worldwide, including in Korea. The BA.3.2 variant, which tends to remain asymptomatic for an extended period before symptoms appear, ...

Cicada is in the Omicron lineage and was first identified in 2024.